[2] Your mental health has gotten worse In some cases, semaglutide can cause changes in mood, including symptoms of anxiety and depression
Tirzepatide agonizes two (GLP-1 and GIP)
Eli Lilly and Company 's Retatrutide Shows Up to 28% Weight Loss in Phase-3 Study Eli Lilly reported promising Phase-3 results for #retatrutide, with the triple agonist therapy demonstrating up to 28% weight loss, marking a major milestone in next-generation obesity treatment innovation
But again, it depends on the specific plan
The strongest results in trials were seen after 6 months, 12 months and beyond
Semaglutide has consistently demonstrated better reductions in HbA1c and body weight compared to placebo and a variety of active comparators, including sitagliptin, exenatide extended release, insulin glargine, dulaglutide, canagliflozin, and liraglutide